Start Evaluation
Share your goals, medical history and medications securely.
GHK-Cu + BPC-157 + TB-500 + Epitalon
An exploratory peptide program centered on healthy-aging interests, recovery and your long-term priorities.
This blend brings copper-peptide, tissue-response and cell-aging research into one clinical discussion. The four ingredients offer distinct research perspectives for exploring healthy-aging and recovery goals together.
Healthy-aging priorities · Recovery · Long-term care planning
Share your goals, medical history and medications securely.
A licensed clinician reviews suitability, risks and alternatives.
If appropriate and available, a prescription proceeds through the licensed pharmacy process.
Ongoing clinical review guides monitoring and refill decisions.
Tap an ingredient for a two-sentence explanation.
GHK-Cu is a copper-binding peptide studied in processes involving collagen and tissue remodeling. Cell and animal findings explain the research interest; they do not establish the results of this program in people.
Animal tissue study ↗BPC-157 is a synthetic peptide studied in animal and laboratory models of tissue response and tendon-cell signaling. These findings are a research rationale, not proof that this program heals injuries in people.
Laboratory tendon-cell study ↗TB-500 has been identified as a fragment of thymosin beta-4, a peptide associated with cell movement and tissue biology. Studies of the full thymosin beta-4 molecule cannot be assumed to demonstrate benefits from TB-500 or this blend.
Ingredient identity study ↗Epitalon is a short synthetic peptide investigated for effects on telomerase and telomeres in cultured cells. Cell-culture findings do not show that this program reverses aging or extends human life.
Cell-culture study ↗Intended goals and biological mechanisms do not establish clinical outcomes for this formulation. Individual response varies; benefits are not guaranteed.
This blend is not proven to extend life, reverse aging or prevent disease. Evidence and safety information for the combination are limited.
Treatment requires individual medical evaluation and a prescription where applicable. It depends on clinician judgment, eligibility, and verified pharmacy and state availability. A program selection does not guarantee treatment.
Compounded medications are not FDA-approved; FDA does not review them for safety, effectiveness or quality before marketing. Approval or evidence for one ingredient or branded medicine does not establish the same for this formulation. Outcomes vary and are not guaranteed.
Discuss adverse effects, interactions, pregnancy or reproductive considerations and appropriate alternatives with your clinician. Formulation, route, dosing and monitoring must be confirmed before treatment.
Read the full medical & treatment information ↗No payment is taken in this preview.
Working monthly prices are shown. Final charges and inclusions remain unconfirmed.